Prices as of 2025-12-11 12:40:39 ET
Ticker Appearances
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
This report is accessible to FSI Pro, FSI Macro, FSI Weekly memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
This report is accessible to FSI Pro, FSI Macro, FSI Weekly memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 17 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Visitor: 2c4bce-4a1783-f0a39d-fcb839-ad2f1a Array ( [cookie] => 2c4bce-4a1783-f0a39d-fcb839-ad2f1a [current_usage] => 17 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.212 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a
Already have an account? Sign In 2c4bce-4a1783-f0a39d-fcb839-ad2f1a